Compound Summary
Compound Name: | 			Tyrphostin 47 | 
Compound CID: | 			667601 | 
Synonyms: | 			Tyrphostin 47 Tyrphostin A47 AG 213 AG-213 118409-60-2 More... | 
Iupac Name: | 			(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enethioamide | 
InChI: | 					InChI=1S/C10H8N2O2S/c11-5-7(10(12)15)3-6-1-2-8(13)9(14)4-6/h1-4,13-14H,(H2,12,15)/b7-3+ | 
InChIKey: | 				ZGHQGWOETPXKLY-XVNBXDOJSA-N | 
Canonical Smiles: | 		C1=CC(=C(C=C1C=C(C#N)C(=S)N)O)O | 
Isomeric Smiles: | 			C1=CC(=C(C=C1/C=C(\C#N)/C(=S)N)O)O | 
Molecular Weight: | 		220.25 | 
Molecular Formula: | 			C10H8N2O2S | 
Molecular Weight: | 		220.25 | 
Molecular Formula: | 			C10H8N2O2S | 
Hydrogen Bond Donor Count: | 			3 | 
Hydrogen Bond Acceptor Count: | 			4 | 
Rotatable Bond Count: | 			2 | 
Heavy Atom Count: | 					15 | 
Complexity: | 				332 | 
| Tyrphostin 47 | Tyrphostin 47 | 
|---|---|
Tyrphostin 47 | 			
Tyrphostin A47 | 
AG 213 | 			
AG-213 | 
118409-60-2 | 			
122520-86-9 | 
RG-50864 | 			
3,4-Dihydroxy-alpha-cyanothiocinnamamide | 
RG 50864 | 			
alpha-Cyano-(3,4-dihydroxy)thiocinnamide | 
CHEMBL77030 | 			
2-Propenethioamide, 2-cyano-3-(3,4-dihydroxyphenyl)- | 
(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enethioamide | 			
tyrphostin AG213 | 
Tyrphostin AG-213 | 			
Tyrphostin RG50864 | 
(2E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enethioamide | 			
2-Propenethioamide, 2-cyano-3-(3,4-dihydroxyphenyl)-, (2E)- | 
3,4-Dihydroxy-alpha-cyanothiocinnamide | 			
RG50864 | 
alpha-Cyano-3,4-dihydroxythiocinnamamide | 			
AG213 | 
3,4-Dihydroxybenzylidenethioacetamide | 			
Tyrphostin A-47 | 
2-Cyano-3-(3,4-dihydroxyphenyl)-2-propenethioamide | 			
Tocris-0503 | 
BiomolKI_000014 | 			
Lopac-T-7540 | 
BiomolKI2_000024 | 			
AG213 (Tyrphostin 47) | 
BMK1-C2 | 			
BSPBio_001392 | 
SCHEMBL239295 | 			
T7540 (Tyrphostin 47) | 
BDBM4363 | 			
SCHEMBL14411466 | 
CHEBI:93703 | 			
DTXSID701018041 | 
HMS1361F14 | 			
HMS1791F14 | 
HMS1989F14 | 			
HMS3402F14 | 
ZINC3871430 | 			
2087AH | 
NSC638083 | 			
AG-213 AG 213 | 
CCG-100618 | 			
NSC-638083 | 
IDI1_033862 | 			
NCGC00016050-01 | 
NCGC00016050-02 | 			
NCGC00016050-03 | 
NCGC00016050-04 | 			
NCGC00016050-05 | 
NCGC00016050-06 | 			
NCGC00024619-01 | 
NCGC00024619-02 | 			
NCGC00024619-03 | 
NCGC00024619-04 | 			
benzylidenemalononitrile (BMN) deriv. 47 | 
2-Cyano-3-(3,4-dihydroxy-phenyl)-thioacrylamide | 			
409A602 | 
SR-01000597611 | 			
SR-01000597611-1 | 
BRD-K96778649-001-01-6 | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 10.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 10.000000000000000 | 1 | 1 |